NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-001-2012-0-CH-09 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen CH EP 13700352.1 Issued
NCI E-001-2012-0-EP-05 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen EP National Stage 13700352.1 Issued
NCI E-001-2012-0-DK-11 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen DK EP 13700352.1 Issued
NCI E-001-2012-0-ES-12 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen ES EP 13700352.1 Issued
NCI E-001-2012-0-SE-17 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen SE EP 13700352.1 Issued
NCI E-001-2012-0-DE-10 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen DE EP 13700352.1 Issued
NCI E-001-2012-0-FR-13 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen FR EP 13700352.1 Issued
NCI E-001-2012-0-IE-15 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen IE EP 13700352.1 Issued
NCI E-001-2012-0-AU-03 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen AU National Stage 2013206896 Issued
NCI E-042-2012-0-AU-03 Methods Of Treating Or Preventing Insulin Resistance And Associated Diseases and Conditions AU National Stage 2013208308 Abandoned
NCI E-001-2012-0-PCT-02 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen PCT PCT PCT/US2013/020058 Expired
NCI E-042-2012-0-PCT-02 Methods Of Treating Or Preventing Insulin Resistance And Associated Diseases and Conditions. PCT PCT PCT/US13/20051 Expired
NIA E-165-2011-0-PCT-02 Human Soluble Receptor For Advanced Glycation End Products (sRAGE) Methods of Preparing Human Srage, And Treatment Methods Using Srage PCT PCT PCT/US2013/020103 Expired
NCI E-042-2012-0-EP-05 Methods Of Treating Or Preventing Insulin Resistance And Associated Diseases and Conditions. EP National Stage 13736174.7 Abandoned
NCI E-042-2012-0-CA-04 Methods Of Treating Or Preventing Insulin Resistance And Associated Diseases and Conditions CA National Stage 2860842 Abandoned
NIAID E-154-2010-1-US-03 METHODS FOR THE INDUCTION OF EBOLA VIRUS-SPECIFIC IMMUNE RESPONSES COMPRISING ADMINISTERING A REPLICATION-DEFECTIVE CHIMPANZEE ADENOVIRUS VECTOR EXPRESSING THE EBOLA VIRUS GLYCOPRETEIN US National Stage 13/641,655 9526777 Issued PDF
NCI E-195-2005-1-US-01 NANOPROBES FOR DETECTION OR MODIFICATION OF MOLECULES US CIP 13/732,029 8703734 Abandoned PDF
NCATS E-043-2013-0-US-01 Inhibitors Of The USP1/UAF1 Deubiquitinase Complex And Uses Thereof US 61/747,052 Abandoned
NHLBI E-017-2012-0-PCT-02 Methods Of Treating Or Preventing Viral Disease By Blocking Interleukin-21 PCT PCT PCT/US12/71173 Expired
NINDS E-143-2002-0-US-11 Zenapax (Humanized Antibody Against the IL-2 Receptor Alpha Chain) As A Novel Treatment for Multiple Sclerosis US CON 13/725,119 Abandoned
NCI E-128-2012-0-US-01 NIK Inhibitors That Selectively Target NIK-Dependent B-Cell Lymphoma US 61/745,422 Abandoned
NCI E-286-2007-0-US-03 Methods for Increasing Levels of Human Fetal Hemoglobin US CON 13/722,995 Abandoned
NIAID E-159-2007-3-US-04 Monoclonal Antibodies Against Dengue And Other Viruses With Deletion IN FC Region US DIV 13/722,275 Abandoned
NCI E-167-2010-0-US-04 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling US National Stage 13/697,259 9475839 Issued PDF
NCI E-203-2011-1-US-02 Discovery Of Novel Inhibitors Of DNA Topoisomerase That Can Be Used For Studying Topoisomerase Functions And For The Treatment Of Human Cancers US National Stage 13/698,739 9181193 Abandoned PDF
NCI E-100-2010-0-US-03 Regulation Of Skin Pigmentation By Neuregulin-I (NRG-1) US National Stage 13/805,638 9168297 Abandoned PDF
NEI E-092-2010-0-US-06 Methods of Treatment Using Sterculic Acid US National Stage 13/805,429 8993626 Abandoned PDF
NCATS E-276-2011-0-CA-04 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis CA National Stage 2859370 Issued
NCATS E-276-2011-0-EP-05 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis EP National Stage 12806846.7 Issued
NCATS E-276-2011-0-IT-15 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis IT EP 12806846.7 Issued
NCATS E-276-2011-0-GB-14 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis GB EP 12806846.7 Issued
NCATS E-276-2011-0-TR-16 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis TR EP 12806846.7 Issued
NCATS E-276-2011-0-FR-13 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis FR EP 12806846.7 Issued
NCATS E-276-2011-0-DE-11 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis DE EP 12806846.7 Issued
NCATS E-276-2011-0-ES-12 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis ES EP 12806846.7 Issued
NCATS E-276-2011-0-AU-03 Compounds And Methods For The Prevention And Treatment Of Tumor Metastasis And Tumorgenesis AU National Stage 2012353651 Issued
NIAID E-279-2011-0-US-02 Methods of Producing T Cell Populations Enriched for Stable Regulatory T-Cells US ORD 13/716,900 9481866 Issued PDF
NCI E-183-2010-0-US-07 Compositions And Methods For Treating Inflammatory Conditions US National Stage 13/704,956 Abandoned
NIDCR E-109-2000-0-US-05 Selective Ablation of Pain-Sensing Neurons By Administration of A Vanilloid Receptor Agonist US CON 13/717,509 Abandoned
NCATS E-276-2011-0-PCT-02 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis PCT PCT PCT/US12/070155 Expired
NICHD E-302-2011-0-PCT-02 Identification Of Two Novel Biomarkers For Niemann-Pick Disease Type C PCT PCT PCT/US2012/069955 Expired
NICHD E-302-2011-0-EP-05 Identification Of Two Novel Biomarkers For Niemann-Pick Disease Type C EP National Stage 12857972.9 Abandoned
NIAID E-240-2012-1-PCT-01 CD-4 Mimetic Inhibitors Of HIV Entry And Methods Of Use Thereof PCT PCT COMB PCT/US12/069708 Expired
NICHD E-302-2011-0-CA-04 Identification Of Two Novel Biomarkers For Niemann-Pick Disease Type C CA National Stage 2859202 Abandoned
NICHD E-302-2011-0-AU-03 Identification Of Two Novel Biomarkers For Niemann-Pick Disease Type C AU National Stage 2012351963 Abandoned
NCI E-074-2007-0-AU-12 BRACHYURY POLYPEPTIDES AND METHODS FOR USE AU DIV 2012261687 Issued
NIAID E-067-2012-0-US-01 HIV NEUTRALIZING PEPTIDES AND METHODS OF THEIR USE US 61/736,350 Abandoned
NHGRI E-096-2013-0-US-01 METHODS FOR TREATING LEUKEMIA AND DISORDERS MEDIATED BY MLL FUSION PROTEINS US 61/736,459 Abandoned
NIAID E-122-2001-0-US-10 Anti-Arthropod Vector Vaccines, Methods of Selecting and Uses Thereof US DIV 13/711,167 8629260 Expired PDF
NCI E-086-2012-1-US-01 Methods For Generation Of Pluripotent and Multipotent Cells US 61/735,701 Abandoned